Literature DB >> 23960823

Box-Behnken supported validation of stability-indicating high performance thin-layer chromatography (HPTLC) method: An application in degradation kinetic profiling of ropinirole.

Gulam Mustafa1, Alka Ahuja, Sanjula Baboota, Javed Ali.   

Abstract

Stability-indicating high-performance thin-layer chromatographic (HPTLC) method for the analysis of ropinirole HCl was developed and validated as per the ICH guidelines. The method employed the mobile phase and toluene-ethyl acetate-6 M ammonia solution (5:6:0.5, v/v/v) was optimized with the help of a design expert. Densitometric analysis of ropinirole HCl was carried out in the absorbance mode at 250 and 254 nm. Compact spots for ropinirole HCl were found at R f value of 0.58 ± 0.02. The linear regression analysis data for the calibration plots showed R (2) = 0.9989 ± 0.0053 with a concentration range of 100-3000 ng spot(-1). The method was validated for precision, accuracy, ruggedness, robustness, specificity, recovery, limit of detection (LOD) and limit of quantitation (LOQ). The LOD and LOQ were 12.95 and 39.25 ng spot(-1) respectively. Drug was subjected to acidic, alkaline, oxidative, dry heat, wet heat and photo degradation stress. All the peaks of degradation products were well resolved from the standard drug peak with significant difference of R f. The acidic and alkaline stress degradation kinetics of ropinirole, were found to be in first order, showing high stability (t 1/2, 146.37 h(-1); t 0.9, 39.11 h(-1)) in the acidic medium and low stability (t 1/2, 97.67 h(-1); t 0.9, 14.87 h(-1)) in the alkaline environment.

Entities:  

Keywords:  Degradation kinetics; Design-expert optimization; HPTLC; Ropinirole; Stability-indicating; Validation

Year:  2011        PMID: 23960823      PMCID: PMC3745077          DOI: 10.1016/j.jsps.2011.11.006

Source DB:  PubMed          Journal:  Saudi Pharm J        ISSN: 1319-0164            Impact factor:   4.330


  11 in total

1.  Rapid and sensitive liquid chromatography-mass spectrometry method for determination of ropinirole in human plasma.

Authors:  Jignesh Bhatt; Arvind Jangid; Raghavendra Shetty; Bhavin Shah; Sandeep Kambli; Gunta Subbaiah; Sadhana Singh
Journal:  J Pharm Biomed Anal       Date:  2005-11-11       Impact factor: 3.935

2.  Isolation and characterization of some potential impurities in ropinirole hydrochloride.

Authors:  B Sahasrabuddhey; R Nautiyal; H Acharya; S Khyade; P K Luthra; P B Deshpande
Journal:  J Pharm Biomed Anal       Date:  2007-01-04       Impact factor: 3.935

3.  Ropinirole in the treatment of patients with restless legs syndrome: a US-based randomized, double-blind, placebo-controlled clinical trial.

Authors:  Richard K Bogan; June M Fry; Markus H Schmidt; Stanley W Carson; Sally Y Ritchie
Journal:  Mayo Clin Proc       Date:  2006-01       Impact factor: 7.616

4.  Application of thermospray liquid chromatography-mass spectrometry and liquid chromatography-tandem mass spectrometry for the identification of cynomolgus monkey and human metabolites of SK & F 101468, a dopamine D2 receptor agonist.

Authors:  I G Beattie; T J Blake
Journal:  J Chromatogr       Date:  1989-07-14

5.  Disposition of ropinirole in animals and man.

Authors:  J V Ramji; J P Keogh; T J Blake; C Broom; R J Chenery; D R Citerone; V A Lewis; A C Taylor; S E Yeulet
Journal:  Xenobiotica       Date:  1999-03       Impact factor: 1.908

6.  Determination of 4-(2-di-n-propylaminoethyl)-7-hydroxy-2-(3H)-indolone and N-[2'-hydroxy-5'-(N,N-di-n-propylaminoethylphenyl)]methane sulfonamide in plasma by high-performance liquid chromatography with electrochemical detection.

Authors:  J E Swagzdis; R Gifford; B A Mico
Journal:  J Chromatogr       Date:  1985-11-29

Review 7.  Ropinirole: a review of its use in the management of Parkinson's disease.

Authors:  A J Matheson; C M Spencer
Journal:  Drugs       Date:  2000-07       Impact factor: 9.546

Review 8.  Clinical pharmacokinetics of ropinirole.

Authors:  C M Kaye; B Nicholls
Journal:  Clin Pharmacokinet       Date:  2000-10       Impact factor: 6.447

9.  Separation and quantification of ropinirole and some impurities using capillary liquid chromatography.

Authors:  P Coufal; K Stulík; H A Claessens; M J Hardy; M Webb
Journal:  J Chromatogr B Biomed Sci Appl       Date:  1999-09-24

Review 10.  Pharmacokinetic optimisation in the treatment of Parkinson's disease : an update.

Authors:  Dag Nyholm
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 5.577

View more
  2 in total

1.  Systematic Development and Validation of a Thin-Layer Densitometric Bioanalytical Method for Estimation of Mangiferin Employing Analytical Quality by Design (AQbD) Approach.

Authors:  Rajneet Kaur Khurana; Satish Rao; Sarwar Beg; O P Katare; Bhupinder Singh
Journal:  J Chromatogr Sci       Date:  2016-02-23       Impact factor: 1.618

Review 2.  Detection progress of selected drugs in TLC.

Authors:  Alina Pyka
Journal:  Biomed Res Int       Date:  2014-01-16       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.